News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
258,669 Results
Type
Article (7120)
Company Profile (68)
Press Release (251480)
Multimedia
Podcasts (12)
Webinars (5)
Section
Business (90390)
Career Advice (531)
Deals (16281)
Drug Delivery (16)
Drug Development (22266)
Employer Resources (39)
FDA (4060)
Job Trends (4445)
News (132817)
Policy (8355)
Tag
2027 Genetown Elite (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (2)
Academia (421)
Accelerated approval (7)
Adcomms (4)
Allergies (20)
Alliances (17323)
ALS (42)
Alzheimer's disease (335)
Antibody-drug conjugate (ADC) (68)
Approvals (4163)
Artificial intelligence (109)
Autoimmune disease (37)
Automation (8)
Bankruptcy (102)
Best Places to Work (3177)
BIOSECURE Act (2)
Biosimilars (43)
Biotechnology (51)
Bladder cancer (37)
Brain cancer (13)
Breast cancer (140)
Cancer (1149)
Cardiovascular disease (69)
Career advice (451)
Career pathing (4)
CAR-T (94)
CDC (3)
Cell therapy (242)
Cervical cancer (7)
Clinical research (19345)
Collaboration (537)
Company closure (2)
Compensation (426)
Complete response letters (8)
COVID-19 (467)
CRISPR (23)
C-suite (415)
Cystic fibrosis (35)
Data (1682)
Denatured (8)
Depression (31)
Diabetes (90)
Diagnostics (2468)
Digital health (13)
Diversity (3)
Diversity, equity & inclusion (13)
Drug discovery (68)
Drug pricing (23)
Drug shortages (2)
Duchenne muscular dystrophy (73)
Earnings (44843)
Editorial (10)
Employer branding (7)
Employer resources (39)
Events (43740)
Executive appointments (504)
FDA (4905)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (4)
Frontotemporal dementia (8)
Funding (476)
Gene editing (54)
Generative AI (8)
Gene therapy (146)
GLP-1 (192)
Government (563)
Guidances (208)
Healthcare (5545)
HIV (12)
Huntington's disease (10)
IgA nephropathy (24)
Immunology and inflammation (71)
Immuno-oncology (22)
Indications (22)
Infectious disease (508)
Inflammatory bowel disease (49)
Inflation Reduction Act (7)
Influenza (15)
Intellectual property (55)
Interviews (60)
IPO (8395)
IRA (8)
Job creations (1334)
Job search strategy (413)
JPM (8)
Kidney cancer (13)
Labor market (20)
Layoffs (147)
Leadership (8)
Legal (2503)
Liver cancer (26)
Longevity (3)
Lung cancer (117)
Lymphoma (78)
Machine learning (6)
Management (14)
Manufacturing (192)
MASH (63)
Medical device (4146)
Medtech (4157)
Mergers & acquisitions (8375)
Metabolic disorders (279)
Multiple sclerosis (38)
NASH (6)
Neurodegenerative disease (78)
Neuropsychiatric disorders (22)
Neuroscience (672)
NextGen: Class of 2026 (1926)
Non-profit (853)
Now hiring (16)
Obesity (114)
Opinion (49)
Ovarian cancer (44)
Pain (49)
Pancreatic cancer (59)
Parkinson's disease (59)
Partnered (9)
Patents (97)
Patient recruitment (125)
Peanut (7)
People (28372)
Pharmaceutical (12)
Pharmacy benefit managers (2)
Phase 1 (6146)
Phase 2 (8507)
Phase 3 (6513)
Pipeline (2251)
Policy (31)
Postmarket research (648)
Preclinical (2435)
Press Release (66)
Prostate cancer (63)
Psychedelics (6)
Radiopharmaceuticals (120)
Rare diseases (229)
Real estate (2187)
Recruiting (13)
Regulatory (6271)
Reports (20)
Research institute (433)
Resumes & cover letters (78)
Rett syndrome (20)
RNA editing (6)
RSV (3)
Schizophrenia (63)
Series A (88)
Series B (72)
Service/supplier (2)
Sickle cell disease (12)
Special edition (4)
Spinal muscular atrophy (35)
Sponsored (6)
Startups (1384)
Stomach cancer (3)
Supply chain (16)
Tariffs (9)
The Weekly (4)
Vaccines (130)
Venture capital (25)
Weight loss (50)
Women's health (16)
Worklife (1)
Date
Today (49)
Last 7 days (224)
Last 30 days (698)
Last 365 days (10650)
2026 (1167)
2025 (10731)
2024 (12785)
2023 (15156)
2022 (20979)
2021 (22166)
2020 (20235)
2019 (14593)
2018 (11252)
2017 (11277)
2016 (10315)
2015 (13329)
2014 (10559)
2013 (8585)
2012 (9413)
2011 (9723)
2010 (9441)
Location
Africa (220)
Alabama (22)
Alaska (2)
Arizona (88)
Arkansas (1)
Asia (13173)
Australia (1898)
California (4645)
Canada (1292)
China (243)
Colorado (178)
Connecticut (179)
Delaware (75)
Europe (28325)
Florida (590)
Georgia (76)
Hawaii (2)
Idaho (27)
Illinois (182)
India (18)
Indiana (157)
Iowa (9)
Japan (179)
Kansas (47)
Kentucky (18)
Louisiana (8)
Maine (51)
Maryland (390)
Massachusetts (3171)
Michigan (114)
Minnesota (221)
Mississippi (2)
Missouri (37)
Montana (17)
Nebraska (13)
Nevada (49)
New Hampshire (20)
New Jersey (1110)
New Mexico (5)
New York (886)
North Carolina (595)
North Dakota (4)
Northern California (2340)
Ohio (146)
Oklahoma (6)
Oregon (11)
Pennsylvania (678)
Puerto Rico (3)
Rhode Island (21)
South America (309)
South Carolina (18)
Southern California (1798)
Tennessee (66)
Texas (614)
United States (14639)
Utah (115)
Virginia (94)
Washington D.C. (20)
Washington State (359)
West Virginia (3)
Wisconsin (65)
Wyoming (1)
258,669 Results for "akston biosciences corporation".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
Dr. Linda Rhodes Joins Akston Biosciences’ Board of Directors
Akston Biosciences Corporation, dedicated to accelerating the biologics revolution in Animal Health, today announced the appointment of Linda Rhodes, VMD, PhD to its Board of Directors.
June 17, 2024
·
3 min read
Genetown
Akston Biosciences’ AKS-452 Vaccine Study Published in Nature, Showcasing Ambifect® Platform’s Versatility
Akston Biosciences, dedicated to accelerating the next revolution in Animal Health, announced the publication in Nature Vaccines of phase II study results for AKS-452, based on Akston’s Ambifect® Fc-fusion protein platform.
February 26, 2024
·
2 min read
Genetown
Akston Biosciences’ AKS-107 Study Published in Frontiers in Immunology, Displaying Ambifect® Platform’s Versatility
Akston Biosciences’ AKS-107 Study Published in Frontiers in Immunology , Displaying Ambifect ® Platform’s Versatility.
March 11, 2024
·
3 min read
Genetown
Akston Biosciences to Focus on Strong Animal Health Pipeline
Akston Biosciences Corporation announced today that it will focus on inventing, developing, and manufacturing breakthrough protein therapeutics for Companion Animal Health, utilizing its versatile Ambifect™ Fc-fusion platform and its Beverly, Massachusetts cGMP biologics manufacturing facility.
August 17, 2023
·
2 min read
Genetown
Akston Biosciences Receives 2023 Most Innovative Award at Animal Health Summit
Akston Biosciences Corporation, which invents, develops and manufactures breakthrough protein therapeutics for Companion Animal Health, received the 2023 Innovation Award at the just-concluded Animal Health Summit in Kansas City, MO.
August 31, 2023
·
2 min read
Press Releases
BD Completes Combination of Biosciences & Diagnostic Solutions Business with Waters Corporation
February 10, 2026
·
5 min read
Genetown
Akston Biosciences CEO to Present at the 2023 Animal Health Summit in Kansas City
Akston Biosciences Corporation, which invents, develops and manufactures breakthrough protein therapeutics for Companion Animal Health, announced that President & CEO Todd Zion, Ph.D., will present at the 2023 Animal Health Summit in Kansas City, MO on August 28, 2023.
August 28, 2023
·
2 min read
Business
Akston Biosciences Strengthens Board with Addition of John T. Preston
Akston Biosciences Corporation, a clinical-stage biotechnology company, today announced that John T. Preston, a founder of TEM Capital, has joined its Board of Directors.
January 23, 2023
·
3 min read
Press Releases
Twist Bioscience Corporation Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4) - February 3, 2026
February 4, 2026
·
2 min read
Press Releases
Enveric Biosciences Reports Third Quarter 2025 Financial and Corporate Results
November 17, 2025
·
9 min read
1 of 25,867
Next
